High-moderate risk changes to permissible ingredients – Vitamin B6 (pyridoxine hydrochloride, pyridoxal 5-phosphate, and pyridoxal 5-phosphate monohydrate)

The TGA collects your personal information in this survey in order to:

1. Contact you, where necessary, to clarify issues raised in your responses, or to confirm whether you consent to certain information that you have provided being made publicly available.
2. Help provide context about your responses (e.g. to determine whether you are an individual or a director of a company or representing an interest group).

Please do not include personal information about other individuals in your responses. Personal information in this context means, information or an opinion about an identified individual, or an individual who is reasonably identifiable, from the information or opinion.

The TGA will not publish personal information about you/others without your/their consent unless authorised or required by law.

Online publication of submissions

The TGA may disclose your full name, work title, company/organisation and submission on the internet (i.e. make this information publicly available) with your consent.

You may specify whether there is anything in your submission that you would prefer not to be published online (e.g. names, email addresses or proprietary information). Please clearly identify the relevant information at the end of your response.